Our mission

We develop advanced regenerative stem cell therapies to fight the devastating consequences of muscle diseases.

MyoPax GmbH, Koppenplatz 5, 10115 Berlin

Commercial register: Amtsgericht Berlin Charlottenburg, HRB 233597 B

VAT DE346703290

CEO: Dr. Verena Schöwel-Wolf

MyoPax GmbH, Berlin, Germany

MyoPax Denmark ApS, C/O Bioinnovation Institute Fond, København, Denmark

Please contact us for more information: